GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Inoviq (ASX:IIQ) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 15, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Inoviq's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Inoviq's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Inoviq's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inoviq's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Inoviq's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Inoviq  (ASX:IIQ) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Inoviq Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Inoviq's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Inoviq Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
ASX:CTE ASX:BDX ASX:RHY ASX:MAP ASX:IBX ASX:GSS TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM ILMN
Traded in Other Exchanges
EGQ0:Germany
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Website
https://www.bard1.com
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq Headlines

No Headlines